Nguyen Lee S, Merzoug Messaouda, Estagnasie Philippe, Brusset Alain, Law Koune Jean-Dominique, Aubert Stephane, Waldmann Thierry, Grinda Jean-Michel, Gibert Hadrien, Squara Pierre
Critical Care Medicine Department, CMC Ambroise Paré, 25-27 Boulevard Victor Hugo, 92200, Neuilly-sur-Seine, France.
Anesthesiology Department, CMC Ambroise Paré, Neuilly-sur-Seine, France.
Trials. 2017 Dec 2;18(1):582. doi: 10.1186/s13063-017-2321-9.
Postoperative pulmonary complications are a leading cause of morbidity and mortality after cardiac surgery. There are no recommendations on mechanical ventilation associated with cardiopulmonary bypass (CPB) during surgery and anesthesiologists perform either no ventilation (noV) at all during CPB or maintain low tidal volume (LTV) ventilation. Indirect evidence points towards better pulmonary outcomes when LTV is performed but no large-scale prospective trial has yet been published in cardiac surgery.
The MECANO trial is a single-center, double-blind, randomized, controlled trial comparing two mechanical ventilation strategies, noV and LTV, during cardiac surgery with CPB. In total, 1500 patients are expected to be included, without any restrictions. They will be randomized between noV and LTV on a 1:1 ratio. The noV group will receive no ventilation during CPB. The LTV group will receive 5 breaths/minute with a tidal volume of 3 mL/kg and positive end-expiratory pressure of 5 cmH2O. The primary endpoint will be a composite of all-cause mortality, early respiratory failure defined as a ratio of partial pressure of oxygen/fraction of inspired oxygen <200 mmHg at 1 hour after arrival in the ICU, heavy oxygenation support (defined as a patient requiring either non-invasive ventilation, mechanical ventilation or high-flow oxygen) at 2 days after arrival in the ICU or ventilator-acquired pneumonia defined by the Center of Disease Control. Lung recruitment maneuvers will be performed in the noV and LTV groups at the end of surgery and at arrival in ICU with an insufflation at +30 cmH20 for 5 seconds. Secondary endpoints are those composing the primary endpoint with the addition of pneumothorax, CPB duration, quantity of postoperative bleeding, red blood cell transfusions, revision surgery requirements, length of stay in the ICU and in the hospital and total hospitalization costs. Patients will be followed until hospital discharge.
The MECANO trial is the first of its kind to compare in a double-blind design, a no-ventilation to a low-tidal volume strategy for mechanical ventilation during cardiac surgery with CPB, with a primary composite outcome including death, respiratory failure and postoperative pneumonia.
ClinicalTrials.gov, NCT03098524 . Registered on 27 February 2017.
术后肺部并发症是心脏手术后发病和死亡的主要原因。对于手术期间与体外循环(CPB)相关的机械通气,目前尚无相关建议,麻醉医生在CPB期间要么完全不进行通气(无通气,noV),要么维持低潮气量(LTV)通气。间接证据表明,实施LTV通气时肺部预后更好,但心脏手术领域尚未发表大规模前瞻性试验。
MECANO试验是一项单中心、双盲、随机对照试验,比较心脏手术CPB期间两种机械通气策略,即noV和LTV。预计共纳入1500例患者,无任何限制。患者将按1:1比例随机分为noV组和LTV组。noV组在CPB期间不进行通气。LTV组将以每分钟5次呼吸、潮气量3 mL/kg和呼气末正压5 cmH2O进行通气。主要终点将是全因死亡率、早期呼吸衰竭(定义为入住重症监护病房(ICU)1小时后氧分压/吸入氧分数<200 mmHg)、入住ICU 2天后重度氧合支持(定义为患者需要无创通气、机械通气或高流量吸氧)或疾病控制中心定义的呼吸机相关性肺炎的复合指标。手术结束时以及入住ICU时,noV组和LTV组都将进行肺复张操作,以+30 cmH20的压力吹入气体5秒。次要终点包括构成主要终点的指标,另外还有气胸、CPB持续时间、术后出血量、红细胞输注量、再次手术需求、ICU住院时间、住院时间以及总住院费用。患者将随访至出院。
MECANO试验是同类试验中首个采用双盲设计,比较心脏手术CPB期间机械通气的无通气与低潮气量策略的试验,主要复合结局包括死亡、呼吸衰竭和术后肺炎。
ClinicalTrials.gov,NCT03098524。于2017年2月27日注册。